Isabelle Brown
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Isabelle Brown has a total of 99 co-authors. Here are the top co-authors by number of shared publications:
Sewon Kang
Department of Dermatology Johns Hopkins University Baltimore Maryland USA
3 shared publications- Sewon Kang
Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland
3 shared publications - Shawn G. Kwatra
Department of Dermatology, University of Maryland School of Medicine, Baltimore, USA
3 shared publications Anna L. Chien
Department of Dermatology Johns Hopkins University Baltimore Maryland USA
2 shared publications- Anna L. Chien
Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
2 shared publications - Bret L. Pinsker
Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA
2 shared publications
Latest Publications
- Open Access
- 13 February 2023
- Published by Wiley in Experimental Dermatology
- Vol. 32 (5) , 641-647
Sex‐specific differences in oxidative stress markers and collagen expression in perioral skin wrinkling
Wrinkling is the hallmark of skin ageing. We previously reported that perioral wrinkling is more severe in females; however, the molecular basis is unknown. This study assessed sex differences in the molecular expression of key ageing regulators in perioral skin. Twelve subjects (n = 6 male/female) were enrolled in this cross‐sectional study and biopsies were taken from the perioral and periocular regions. RNA expression of collagen I, collagen III, cysteine‐rich angiogenic inducer 61 (CYR61) and insulin‐like growth factor 1 (IGF‐1) was assessed by qPCR. There was no difference between females' and males' Griffith's grades (6 and 5.67, respectively, p = 0.092) or periocular wrinkling grades (3.2 and 2.6, p = 0.421), but females had more severe perioral wrinkling grades than males (6.2 and 2.8, p = 0.020). Females not only expressed significantly more CYR61 (p = 0.018) in the perioral region than malesm but also expressed more collagen III (p = 0.016). There was no difference in collagen I (p = 0.115) or IGF‐1 (p = 0.124) expression in the perioral region between sexes. In the periocular region, there were no significant differences between sexes in the expression of all four markers. The significant molecular differences in the perioral region between the sexes may contribute to the greater perioral skin wrinkling seen clinically in females.
- 13 February 2023
- Published by Wiley in Experimental Dermatology
- Vol. 32 (5) , 641-647
Open AccessSex‐specific differences in oxidative stress markers and collagen expression in perioral skin wrinkling
Wrinkling is the hallmark of skin ageing. We previously reported that perioral wrinkling is more severe in females; however, the molecular basis is unknown. This study assessed sex differences in the molecular expression of key ageing regulators in perioral skin. Twelve subjects (n = 6 male/female) were enrolled in this cross‐sectional study and biopsies were taken from the perioral and periocular regions. RNA expression of collagen I, collagen III, cysteine‐rich angiogenic inducer 61 (CYR61) and insulin‐like growth factor 1 (IGF‐1) was assessed by qPCR. There was no difference between females' and males' Griffith's grades (6 and 5.67, respectively, p = 0.092) or periocular wrinkling grades (3.2 and 2.6, p = 0.421), but females had more severe perioral wrinkling grades than males (6.2 and 2.8, p = 0.020). Females not only expressed significantly more CYR61 (p = 0.018) in the perioral region than malesm but also expressed more collagen III (p = 0.016). There was no difference in collagen I (p = 0.115) or IGF‐1 (p = 0.124) expression in the perioral region between sexes. In the periocular region, there were no significant differences between sexes in the expression of all four markers. The significant molecular differences in the perioral region between the sexes may contribute to the greater perioral skin wrinkling seen clinically in females.
- 1 November 2022
- Published by Wiley in Photodermatology, Photoimmunology & Photomedicine
- Vol. 39 (4) , 332-342
Skin type specific photobiological response to visible light is mediated by constitutional melanin
Background: Visible light (VL) induces varying photobiological responses between skin types, likely influenced by inherent melanization. Individual typology angle (ITA) objectively measures skin types. We hypothesize that epidermal melanin content and distribution determine VL response.Objectives: This study describes clinical and histologic responses to VL and examines the potential role of melanin in the underlying mechanistic pathways.Methods: We grouped enrolled participants by ITA (Light = 5, Intermediate = 4, Dark = 7) per colorimetry (CR‐400, Konica Minolta). Photoprotected sites were exposed daily to 480 J/cm2 of VL (Fiber‐Lite High Intensity Illuminator, Series 180, Dolan Jenner Industries Inc.) for 4 days (total = 1920 J/cm2), as tolerated. Treated and control sites were biopsied 96 h after first exposure. We used hematoxylin and eosin and Fontana‐Mason to assess histological changes and melanin deposition, respectively. p53 and Ki67 immunohistochemical stains were done to assess DNA damage and proliferation. Matrix metalloproteinase (MMP)‐1 expression was detected by immunohistochemical staining and immunofluorescence microscopy.Results: Darker skin did not tolerate the full VL regimen with blistering occurring in most subjects at doses of 220–880 J/cm2. Intermediate and Dark skin showed tanning. Light skin developed erythema. p53 counts were highest in Intermediate, followed by Light skin, although this was not statistically significant. VL treatment led to MMP‐1 expression and nuclear localization in keratinocytes in Dark and Intermediate but not in Light skin, however differences between groups were not statistically significant.Conclusions: Skin types demonstrate unique biological responses to VL. The role of melanin in photoprotection is well‐defined. However, given the pro‐apoptotic function of nuclear MMPs, we suggest a potential mechanism by which melanin may mediate VL‐induced phototoxicity.
- 1 November 2022
- Published by Wiley in Photodermatology, Photoimmunology & Photomedicine
- Vol. 39 (4) , 332-342
Skin type specific photobiological response to visible light is mediated by constitutional melanin
Background: Visible light (VL) induces varying photobiological responses between skin types, likely influenced by inherent melanization. Individual typology angle (ITA) objectively measures skin types. We hypothesize that epidermal melanin content and distribution determine VL response.Objectives: This study describes clinical and histologic responses to VL and examines the potential role of melanin in the underlying mechanistic pathways.Methods: We grouped enrolled participants by ITA (Light = 5, Intermediate = 4, Dark = 7) per colorimetry (CR‐400, Konica Minolta). Photoprotected sites were exposed daily to 480 J/cm2 of VL (Fiber‐Lite High Intensity Illuminator, Series 180, Dolan Jenner Industries Inc.) for 4 days (total = 1920 J/cm2), as tolerated. Treated and control sites were biopsied 96 h after first exposure. We used hematoxylin and eosin and Fontana‐Mason to assess histological changes and melanin deposition, respectively. p53 and Ki67 immunohistochemical stains were done to assess DNA damage and proliferation. Matrix metalloproteinase (MMP)‐1 expression was detected by immunohistochemical staining and immunofluorescence microscopy.Results: Darker skin did not tolerate the full VL regimen with blistering occurring in most subjects at doses of 220–880 J/cm2. Intermediate and Dark skin showed tanning. Light skin developed erythema. p53 counts were highest in Intermediate, followed by Light skin, although this was not statistically significant. VL treatment led to MMP‐1 expression and nuclear localization in keratinocytes in Dark and Intermediate but not in Light skin, however differences between groups were not statistically significant.Conclusions: Skin types demonstrate unique biological responses to VL. The role of melanin in photoprotection is well‐defined. However, given the pro‐apoptotic function of nuclear MMPs, we suggest a potential mechanism by which melanin may mediate VL‐induced phototoxicity.
- 1 August 2022
- Published by Wiley in Photodermatology, Photoimmunology & Photomedicine
- Vol. 39 (3) , 204-212
Clinical and molecular change induced by repeated low‐dose visible light exposure in both light‐skinned and dark‐skinned individuals
Background: Visible light (VL) is known to induce pigmentation in dark‐skinned individuals and immediate erythema in light‐skinned individuals. However, the effects of accumulated low‐dose VL exposure across skin types are not well established.Methods: Thirty‐one healthy subjects with light (Fitzpatrick skin types [FST] I‐II, n = 13) and dark (FST V‐VI, n = 18) skin types were enrolled. Subjects' buttocks were exposed daily to VL, wavelength 400–700 nm, with a dose of 120 J/cm2 at 50 mW/cm2, for four consecutive days. Microarray using Affymetrix GeneChip (49,395 genes) was performed followed by qRT‐PCR on skin samples.Results: Repeated low‐dose VL irradiation induced immediate pigment darkening and delayed tanning in dark‐skinned individuals while no discernable pigmentation and erythema were observed in light‐skinned individuals. Top ten upregulated genes by repeated VL exposure in microarray included melanogenic genes such as tyrosinase (TYR), tyrosinase‐related protein‐1 (TYRP1), dopachrome tautomerase (DCT), premelanosome protein (PMEL), melan‐A (MLANA), and solute carrier family 24, member 5 (SLC24A5) and genes involved in inflammation/matrix remodeling/cell signaling including chemokine (C‐C motif) ligand 18 (CCL18), BCL2‐related protein A1 (BCL2A1), and cartilage oligomeric matrix protein (COMP). In qRT‐PCR CCL18 was upregulated in light skin with a greater extent (mean fold change ± SD; 4.03 ± 3.28, p = .04) than in dark‐skinned individuals (1.91 ± 1.32, p = .07) while TYR was not significantly upregulated in both skin types.Conclusion: This study highlights the genes upregulated by cumulative VL exposure involved in pigmentation, immune response, oxidation/reduction, and matrix remodeling across skin types providing relevant information on daily solar exposure.
- 1 August 2022
- Published by Wiley in Photodermatology, Photoimmunology & Photomedicine
- Vol. 39 (3) , 204-212
Clinical and molecular change induced by repeated low‐dose visible light exposure in both light‐skinned and dark‐skinned individuals
Background: Visible light (VL) is known to induce pigmentation in dark‐skinned individuals and immediate erythema in light‐skinned individuals. However, the effects of accumulated low‐dose VL exposure across skin types are not well established.Methods: Thirty‐one healthy subjects with light (Fitzpatrick skin types [FST] I‐II, n = 13) and dark (FST V‐VI, n = 18) skin types were enrolled. Subjects' buttocks were exposed daily to VL, wavelength 400–700 nm, with a dose of 120 J/cm2 at 50 mW/cm2, for four consecutive days. Microarray using Affymetrix GeneChip (49,395 genes) was performed followed by qRT‐PCR on skin samples.Results: Repeated low‐dose VL irradiation induced immediate pigment darkening and delayed tanning in dark‐skinned individuals while no discernable pigmentation and erythema were observed in light‐skinned individuals. Top ten upregulated genes by repeated VL exposure in microarray included melanogenic genes such as tyrosinase (TYR), tyrosinase‐related protein‐1 (TYRP1), dopachrome tautomerase (DCT), premelanosome protein (PMEL), melan‐A (MLANA), and solute carrier family 24, member 5 (SLC24A5) and genes involved in inflammation/matrix remodeling/cell signaling including chemokine (C‐C motif) ligand 18 (CCL18), BCL2‐related protein A1 (BCL2A1), and cartilage oligomeric matrix protein (COMP). In qRT‐PCR CCL18 was upregulated in light skin with a greater extent (mean fold change ± SD; 4.03 ± 3.28, p = .04) than in dark‐skinned individuals (1.91 ± 1.32, p = .07) while TYR was not significantly upregulated in both skin types.Conclusion: This study highlights the genes upregulated by cumulative VL exposure involved in pigmentation, immune response, oxidation/reduction, and matrix remodeling across skin types providing relevant information on daily solar exposure.
- 20 May 2022
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 142 (11) , 2896-2908.e4
Cutaneous Toxicities Associated with Immune Checkpoint Inhibitors: An Observational, Pharmacovigilance Study
- 20 May 2022
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 142 (11) , 2896-2908.e4
Cutaneous Toxicities Associated with Immune Checkpoint Inhibitors: An Observational, Pharmacovigilance Study
- 1 September 2021
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 141 (9) , 2208-2218.e14
Prurigo Nodularis Is Characterized by Systemic and Cutaneous T Helper 22 Immune Polarization
- 1 September 2021
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 141 (9) , 2208-2218.e14
Prurigo Nodularis Is Characterized by Systemic and Cutaneous T Helper 22 Immune Polarization
- 1 June 2021
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 141 (6) , 1604-1608
Cutaneous T-Cell Lymphoma Skin Microbiome Is Characterized by Shifts in Certain Commensal Bacteria but not Viruses when Compared with Healthy Controls
- 1 June 2021
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 141 (6) , 1604-1608
Cutaneous T-Cell Lymphoma Skin Microbiome Is Characterized by Shifts in Certain Commensal Bacteria but not Viruses when Compared with Healthy Controls
- 11 December 2020
- Published by Taylor & Francis in Expert Review of Clinical Pharmacology
- Vol. 14 (1) , 67-77
Pathophysiology, diagnosis, and pharmacological treatment of prurigo nodularis
Prurigo nodularis (PN) is a chronic inflammatory skin disease characterized by intensely pruritic, hyperkeratotic nodules distributed on the trunk and extensor surfaces of the extremities. PN has a...
- 11 December 2020
- Published by Taylor & Francis in Expert Review of Clinical Pharmacology
- Vol. 14 (1) , 67-77
Pathophysiology, diagnosis, and pharmacological treatment of prurigo nodularis
Prurigo nodularis (PN) is a chronic inflammatory skin disease characterized by intensely pruritic, hyperkeratotic nodules distributed on the trunk and extensor surfaces of the extremities. PN has a...
- 19 July 2019
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 45 (2) , 202-206
Lessons learned from the development of a hidradenitis suppurativa xenograft mouse model
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease originating from the pilosebaceous unit, in which patients develop painful abscesses, sinus tracts, nodules and scarring, typically in intertriginous areas. Major gaps in our understanding of HS exist, and these may be partially due to the lack of an animal model for experimental studies. We developed an HS xenograft mouse model using human HS lesions grafted onto immunocompromised mice. Although the model had its limitations, several informative lessons were learned, which may contribute to future attempts at an HS animal model.
- 19 July 2019
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 45 (2) , 202-206
Lessons learned from the development of a hidradenitis suppurativa xenograft mouse model
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease originating from the pilosebaceous unit, in which patients develop painful abscesses, sinus tracts, nodules and scarring, typically in intertriginous areas. Major gaps in our understanding of HS exist, and these may be partially due to the lack of an animal model for experimental studies. We developed an HS xenograft mouse model using human HS lesions grafted onto immunocompromised mice. Although the model had its limitations, several informative lessons were learned, which may contribute to future attempts at an HS animal model.
- 20 February 2019
- Published by Wolters Kluwer Health in Journal of Bone and Joint Surgery
- Vol. 101 (4) , e12
In Vivo Bioluminescence Imaging in a Rabbit Model of Orthopaedic Implant-Associated Infection to Monitor Efficacy of an Antibiotic-Releasing Coating
Background: In vivo bioluminescence imaging (BLI) provides noninvasive monitoring of bacterial burden in animal models of orthopaedic implant-associated infection (OIAI). However, technical limitations have limited its use to mouse and rat models of OIAI. The goal of this study was to develop a larger, rabbit model of OIAI using in vivo BLI to evaluate the efficacy of an antibiotic-releasing implant coating. Methods: A nanofiber coating loaded with or without linezolid-rifampin was electrospun onto a surgical-grade locking peg. To model OIAI in rabbits, a medial parapatellar arthrotomy was performed to ream the femoral canal, and a bright bioluminescent methicillin-resistant Staphylococcus aureus (MRSA) strain was inoculated into the canal, followed by retrograde insertion of the coated implant flush with the articular surface. In vivo BLI signals were confirmed by ex vivo colony-forming units (CFUs) from tissue, bone, and implant specimens. Results: In this rabbit model of OIAI (n = 6 rabbits per group), implants coated without antibiotics were associated with significantly increased knee width and in vivo BLI signals compared with implants coated with linezolid-rifampin (p < 0.001 and p < 0.05, respectively). On day 7, the implants without antibiotics were associated with significantly increased CFUs from tissue (mean [and standard error of the mean], 1.4 × 108 ± 2.1 × 107 CFUs; p < 0.001), bone (6.9 × 106 ± 3.1 × 106 CFUs; p < 0.05), and implant (5.1 × 105 ± 2.2 × 105 CFUs; p < 0.05) specimens compared with implants with linezolid-rifampin, which demonstrated no detectable CFUs from any source. Conclusions: By combining a bright bioluminescent MRSA strain with modified techniques, in vivo BLI in a rabbit model of OIAI demonstrated the efficacy of an antibiotic-releasing coating. Clinical Relevance: The new capability of in vivo BLI for noninvasive monitoring of bacterial burden in larger-animal models of OIAI may have important preclinical relevance.
- 20 February 2019
- Published by Wolters Kluwer Health in Journal of Bone and Joint Surgery
- Vol. 101 (4) , e12
In Vivo Bioluminescence Imaging in a Rabbit Model of Orthopaedic Implant-Associated Infection to Monitor Efficacy of an Antibiotic-Releasing Coating
Background: In vivo bioluminescence imaging (BLI) provides noninvasive monitoring of bacterial burden in animal models of orthopaedic implant-associated infection (OIAI). However, technical limitations have limited its use to mouse and rat models of OIAI. The goal of this study was to develop a larger, rabbit model of OIAI using in vivo BLI to evaluate the efficacy of an antibiotic-releasing implant coating. Methods: A nanofiber coating loaded with or without linezolid-rifampin was electrospun onto a surgical-grade locking peg. To model OIAI in rabbits, a medial parapatellar arthrotomy was performed to ream the femoral canal, and a bright bioluminescent methicillin-resistant Staphylococcus aureus (MRSA) strain was inoculated into the canal, followed by retrograde insertion of the coated implant flush with the articular surface. In vivo BLI signals were confirmed by ex vivo colony-forming units (CFUs) from tissue, bone, and implant specimens. Results: In this rabbit model of OIAI (n = 6 rabbits per group), implants coated without antibiotics were associated with significantly increased knee width and in vivo BLI signals compared with implants coated with linezolid-rifampin (p < 0.001 and p < 0.05, respectively). On day 7, the implants without antibiotics were associated with significantly increased CFUs from tissue (mean [and standard error of the mean], 1.4 × 108 ± 2.1 × 107 CFUs; p < 0.001), bone (6.9 × 106 ± 3.1 × 106 CFUs; p < 0.05), and implant (5.1 × 105 ± 2.2 × 105 CFUs; p < 0.05) specimens compared with implants with linezolid-rifampin, which demonstrated no detectable CFUs from any source. Conclusions: By combining a bright bioluminescent MRSA strain with modified techniques, in vivo BLI in a rabbit model of OIAI demonstrated the efficacy of an antibiotic-releasing coating. Clinical Relevance: The new capability of in vivo BLI for noninvasive monitoring of bacterial burden in larger-animal models of OIAI may have important preclinical relevance.